CWM
KRYS icon

CIBC World Markets’s Krystal Biotech KRYS Stock Holding History

CIBC World Markets’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$404K Buy
+1,640
New +$345K ﹤0.01% 875
2025
Q2 		$420K Sell
3,055
-2,449
-44% -$360K ﹤0.01% 942
2025
Q1 		$992K Buy
5,504
+3,183
+137% +$535K 0.01% 692
2024
Q4 		$364K Buy
+2,321
New +$412K ﹤0.01% 853

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CIBC World Markets's KRYS Position: Q4 2025 in Review

CIBC World Markets opened a new position in Krystal Biotech (KRYS) in Q4 2025: 1,640 shares worth $404K. The stake represents ﹤0.01% of the portfolio and ranks #875 among its holdings. This is a return to the name: CIBC World Markets previously reported a position in KRYS as recently as Q2 2025.

CIBC World Markets first reported a position in KRYS in Q4 2024 and has held it in 4 quarters since. The position peaked at $992K in Q1 2025. 334 funds tracked by Wall St. Rank hold KRYS as of Q4 2025.

  • CIBC World Markets held 1,640 shares of Krystal Biotech worth $404K as of Q4 2025.
  • Krystal Biotech was a new CIBC World Markets position in Q4 2025.
  • Krystal Biotech made up ﹤0.01% of CIBC World Markets's portfolio in Q4 2025, its #875 holding.
  • CIBC World Markets first reported a position in Krystal Biotech in Q4 2024 and has held it in 4 quarters since.
  • CIBC World Markets's Krystal Biotech position peaked at $992K in Q1 2025.
  • 334 funds tracked by Wall St. Rank held Krystal Biotech as of Q4 2025.

Based on CIBC World Markets's 13F filing for Q4 2025, filed 12 Feb 2026.